ARCHIVES

Push to Get Exceptions, Adjustments For Clinical Research In DRG Regulations Gaining Momentum

This article is from The Cancer Letter archive.

Vol. 09 No. 29 | July 22, 1983

Download PDF Visit The Full Archive

Related Articles

Phase III Avastin Trial Fails Primary Endpoints

February 28, 2014

Insurers Increasingly Willing To Cover ABMT For Breast Cancer, GAO Finds

June 7, 1996

ORI takes Over Misconduct Inquiry Of NSABP Officials

July 29, 1994

FDA Pettiness Holds Up Trials with Promising Anticancer Drugs

November 14, 1975

$2.5 Million NCI Grant To Fund Brachytherapy Improvement

February 27, 2004

Prevention Trial Could Stand On Its Own

October 28, 1994